Views & Analysis Behind the buzz of real-world data and real-world evidence Putting the who, where and why of real-world studies into context.
Views & Analysis Web and mobile technologies for health economics modelling Digital apps are more agile than longstanding solutions and allow tailored interrogation of data.
Views & Analysis Tracking studies: moving with the times Awareness, Trial, and Usage tracking can be enhanced if technology updates it in real time.
Views & Analysis Data: underpinning health R&D Big data initiatives positioning the UK as a desirable location for R&D.
Views & Analysis The biggest NHS deficit: not money but data Information gleaned from data is the key to making health services safer, more efficient and cost effective.
Views & Analysis Finding your voice: big data’s big potential in scientific d... Examining the reach, quantity and quality of medical and pharma company outputs.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
